Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02264860 · ClinicalTrials.gov registry record · NA
Researching Alveolar Macrophage Improvements With Supplements in HIV
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT02264860 is a NA study that has completed, run by Emory University. The registered enrollment target is 67 participants.
The verdict
NCT02264860, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
HIV infection causes systemic zinc deficiency and oxidative stress that impairs host immunity in the alveolar space.The purpose of this study is to see if taking two nutritional supplements, zinc and SAMe (S-adenosylmethionine), can improve lung health and immune function in persons with HIV. The investigators hypothesize that long-term dietary supplementation with zinc and the glutathione precursor SAMe will enhance pulmonary host immune function in HIV-infected individuals who do not respond adequately to ART alone.
Interventions
- DIETARY_SUPPLEMENT Zinc and SAMe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02264860
The ClinicalTrials.gov registry entry for NCT02264860 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zinc and SAMe is the first listed.
NCT02264860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02264860 about?
NCT02264860 is a clinical study titled "Researching Alveolar Macrophage Improvements With Supplements in HIV". HIV infection causes systemic zinc deficiency and oxidative stress that impairs host immunity in the alveolar space.The purpose of this study is to see if taking two nutritional supplements, zinc and SAMe (S-adenosylmethionine), can improve lung health and immune function in persons with HIV. The i...
What is the current status of trial NCT02264860?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2014-10. Estimated completion is 2018-12-15.
What interventions are being tested in trial NCT02264860?
The interventions under investigation include: Zinc and SAMe (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02264860?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.